The new iteration of C3 Pharmaceuticals, Inc. announced that it executed a tailored Share Subscription Agreement (SSA) with ...

Executives are fighting back against a federal court decision that banned them from the securities industry and ordered them ...

In conversation with experts, we’ll break down what you need to know about the most commonly prescribed type of contraception in the United States: the pill. “The most common and most familiar ...

Ronnel Jaraba, 30, was found lifeless along the C3 Road in Metro Manila on Jan. 26. According to his family, he was a former drug user but stopped when he became a father of two kids. His wake ...

With school back in session, Purdue University saw a record number of applicants. Wall Street analyst Jane King says Purdue ...

The drug has come to AZ from its acquisition of rare ... In 2020, it failed a phase 2 trial in C3 glomerulopathy (C3G) and was discontinued for that indication. AZ/Alexion are also developing ...

Renovations continue to go well for Revive Inc., as they work to turn the former C3 Hotel into a drug and alcohol treatment ...

Shares of Zentalis Pharmaceuticals ZNTL gained 13.6% on Monday after it announced that the FDA has lifted the partial ...

After multiple tests and ultrasounds, doctors discovered multiple lesions on her liver. Biopsies revealed that Ayesha had stage 4 cholangiocarcinoma, a rare form of bile duct cancer that had spread to ...

"We are grateful to the FDA for their collaboration and review of our complete response package, which included a comprehensive safety assessment of the azenosertib program,” said Kimberly Blackwell, ...

Novartis has chalked up another clinical trial win for its targeted factor B inhibitor iptacopan as it strives to position the drug as a patient ... and rare kidney diseases C3 glomerulopathy ...

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Zentalis Pharmaceuticals (ZNTL – Research Report) yesterday and set a ...